ANI Pharmaceuticals Inc
SWB:BSFA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ANI Pharmaceuticals Inc
SWB:BSFA
|
US |
|
Fangzhou Inc
F:5UD
|
CN |
|
L
|
L'Occitane International SA
XMUN:COC
|
LU |
|
Galaxy Digital Holdings Ltd
F:7LX
|
US |
|
W
|
Wizz Air Holdings PLC
OTC:WZZAF
|
CH |
|
Power Solutions International Inc
NASDAQ:PSIX
|
US |
|
A
|
Aurora Energy Metals Ltd
ASX:1AE
|
AU |
|
N
|
NIB Holdings Ltd
F:3GU
|
AU |
|
Q
|
Quidel Corp
F:QL1
|
US |
|
Y
|
Yandex NV
F:YDX
|
NL |
Wall St Price Targets
BSFA Price Targets Summary
ANI Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for BSFA is 96.08 EUR with a low forecast of 78.45 EUR and a high forecast of 112.37 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BSFA's stock price target?
Price Target
96.08
EUR
According to Wall Street analysts, the average 1-year price target for BSFA is 96.08 EUR with a low forecast of 78.45 EUR and a high forecast of 112.37 EUR.
What is the Revenue forecast for ANI Pharmaceuticals Inc?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 73%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for ANI Pharmaceuticals Inc?
Projected CAGR
20%
The compound annual growth rate for Operating Income over the next 8 years is 20%.
What is the Net Income forecast for ANI Pharmaceuticals Inc?
Projected CAGR
20%
The compound annual growth rate for Net Income over the next 8 years is 20%.
